Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02954536
Title Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

esophagus adenocarcinoma

gastric adenocarcinoma

gastroesophageal adenocarcinoma

Therapies

Capecitabine + Cisplatin + Pembrolizumab + Trastuzumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.